The IGF-derived tripeptide Gly-Pro-Glu is a weak NMDA receptor agonist

Christopher E. Vaaga, Kenneth R. Tovar, Gary L. Westbrook

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'The IGF-derived tripeptide Gly-Pro-Glu is a weak NMDA receptor agonist'. Together they form a unique fingerprint.

Medicine & Life Sciences